Dr. Reddy's Omeprazole Capsules Recall: Foreign Tablets Found
Dr. Reddy's recalls 20mg omeprazole capsules with foreign Divalproex Sodium tablets. Consumers should check NDC 82009-022-10 and lot C2403017 for affected products.
Lower-risk recall
Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 20mg omeprazole capsules that contain foreign Divalproex Sodium tablets. This could cause harm if taken by mistake, as the foreign tablets are not intended for use. Read more at govinfonow.com/recall/32006-dr-reddy-s-omeprazole-capsules-recall-foreign-tablets-found.
Source Summary by GovInfoNow · govinfonow.com/recall/32006-dr-reddy-s-omeprazole-capsules-recall-foreign-tablets-found · Updated August 17, 2026 · FDA enforcement record: FDA #D-0525-2025
Cite this page
“Dr. Reddy's Omeprazole Capsules Recall: Foreign Tablets Found.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32006-dr-reddy-s-omeprazole-capsules-recall-foreign-tablets-found. Based on FDA recall #D-0525-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0525-2025%22&limit=1).
Why it’s dangerous
The capsules contain foreign Divalproex Sodium Extended-Release tablets that are not meant to be taken with omeprazole. If someone takes the foreign tablets by mistake, it could cause harm due to the different medication.
Who’s affected
People who have the specific 20mg omeprazole capsules with NDC 82009-022-10 and lot number C2403017. Those taking omeprazole for acid reflux or ulcers are most at risk if they accidentally consume the foreign tablets.
How to tell if you have this one
Check for the NDC code 82009-022-10 and lot number C2403017 on the product label. The product is a 1000-count bottle of 20mg omeprazole capsules, prescription-only.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Product Label
Look for NDC 82009-022-10 and lot number C2403017 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 23 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0525-2025 (June 30, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0525-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.